Senate Report: Biden FDA Ignored Early COVID-19 Vaccine Safety Warnings

Published: Wednesday, April 29, 2026 at 6:30 pm

Senate Report Alleges FDA Ignored Early COVID-19 Vaccine Safety Warnings

A newly released Senate report accuses health officials within the Biden administration of disregarding early warning signs of potential adverse events associated with COVID-19 vaccines. The report, compiled by the Senate Permanent Subcommittee on Investigations, focuses on the findings of an FDA safety data expert who employed an alternative data analysis method.

The report highlights that Dr. Ana Szarfman, a senior medical officer at the FDA, utilized a modified data-mining approach to account for a known limitation called masking, which can obscure safety signals in large datasets. Working with Dr. William DuMouchel, then chief statistician at Oracle, Szarfman's analysis identified approximately 25 statistically significant safety signals for adverse events, including conditions like sudden cardiac death and Bell's palsy, that were not detected by the FDA's standard methodology.

The report details that Szarfman shared her findings with FDA officials beginning in March 2021, but instead of taking action, officials appeared to dismiss her concerns. Internal communications cited in the report reveal that officials expressed concern about how Szarfman's analyses might be perceived and the potential for fueling anti-vaccination sentiment. The report also indicates that Szarfman was later instructed to cease creating and distributing data-mining reports. Furthermore, the report notes that the FDA reduced distribution of weekly data-mining reports, with one official suggesting the decision may have been influenced by public records concerns.

The report concludes that the timing of these actions is suspect, particularly in light of public and congressional requests for information. It suggests that officials may have taken steps to limit the distribution of safety data to avoid further scrutiny.

BNN's Perspective:

This report raises serious questions about transparency and the prioritization of public health during the vaccine rollout. While the report's findings are concerning, it's crucial to acknowledge the unprecedented nature of the pandemic and the pressure to quickly develop and distribute vaccines. A thorough investigation is warranted to determine whether any actions taken by the FDA were inappropriate and to ensure that future vaccine safety monitoring is robust and transparent.

Keywords: Senate Report, FDA, COVID-19 Vaccine, Safety Warnings, Adverse Events, Data Analysis, Masking, Dr. Ana Szarfman, Dr. William DuMouchel, Statistically Significant, Vaccine Side Effects, Biden Administration, Public Health, Transparency, Vaccine Safety, Data Mining, Bell's Palsy, Sudden Cardiac Death

Full Story